|
|
Volumn 47, Issue 10, 2007, Pages 1459-
|
|
PRO-513 for acute migraine treatment
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMIGRAINE AGENT;
DICLOFENAC POTASSIUM;
PLACEBO;
PRO 513;
TRIPTAN DERIVATIVE;
UNCLASSIFIED DRUG;
ANALGESIA;
ARTICLE;
CLINICAL TRIAL;
DEMOGRAPHY;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DIZZINESS;
DRUG EFFICACY;
DRUG SAFETY;
DYSPEPSIA;
HUMAN;
MIGRAINE;
NAUSEA;
PHONOPHOBIA;
PHOTOPHOBIA;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
VOMITING;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DICLOFENAC;
DOUBLE-BLIND METHOD;
DRUG EVALUATION;
HUMANS;
MIGRAINE DISORDERS;
TIME FACTORS;
|
|
EID: 36749044854
PISSN: 00178748
EISSN: 15264610
Source Type: Journal
DOI: 10.1111/j.1526-4610.2007.00944.x Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|